Gabon vs Moldova: Access to anti-retroviral drugs, female (%)
Gabon
63.0%
in 2024
Moldova
62.0%
in 2024
Gabon rank
96th
Moldova rank
99th
Access to anti-retroviral drugs, female (%) over time
- Gabon
- Moldova
How they compare
Gabon currently reports 63.0% against 62.0% in Moldova, a difference of 1.0%.
The two have swapped places 3 times across 25 shared years of data; in 2000 it was Moldova ahead.
Gabon ranks 96th and Moldova ranks 99th of 141 countries.
Across the 3 decades both report, Gabon averaged higher in 2 and Moldova in 1.
Head to head by decade
| Decade | Gabon | Moldova | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 6.9% | 1.4% | 5.5% | Gabon |
| 2010s | 36.7% | 27.8% | 8.9% | Gabon |
| 2020s | 53.4% | 56.4% | 3.0% | Moldova |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, female, Gabon or Moldova?
- Gabon, at 63.0% against 62.0% in Moldova as of 2024.
- What is the difference in access to anti-retroviral drugs, female between Gabon and Moldova?
- 1.0%, with Gabon ahead.
- How many years of comparable data are there for Gabon and Moldova?
- 25 years are reported by both, from 2000 to 2024.
- How do Gabon and Moldova rank globally for access to anti-retroviral drugs, female?
- Gabon ranks 96th and Moldova ranks 99th of 141 countries.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, female (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult females living with HIV who are receiving antiretroviral therapy.